Teddy European Network of Excellence for Paediatric Research was funded in 2005 with the aim to favor the integration of the paediatric pharmacological research activities and contribute to the promotion of safe and efficacious medicines for children.

TEDDY is a Network of Excellence (NoE), strongly proactive in the promotion and implementation of adequate health policies and a social awareness on the importance of the paediatric medicines across Europe.

Today, TEDDY is an independent multidisciplinary, multinational Network composed of partners from more than 20 countries aimed at facilitating the performance of good quality paediatric studies and research.

TEDDY is a category 1 network member of Enpr-EMA, the European Network of Paediatric Research at the European Medicines Agency.

Moreover, TEDDY is member of Enpr-EMA Coordinating Group.

Latest News

2502, 2021

Strengthening children’s participation in their health: the new initiative of the Council of Europe

The Lancet Child Adolescents Health published the article ‘Strengthening children's participation in their health: the new initiative of the Council of Europe’ which was written by the TEDDY Chair, Annagrazia Altavilla, together with

2502, 2021

Paediatric clinical research in Europe: an insight on experts’ needs and perspectives

The Contemporary Clinical Trials Communications journal has published the article: ‘Paediatric clinical research in Europe: An insight on experts’ needs and perspectives’ which concerns the results of a cross-sectional, closed-ended questionnaire prepared within